NOXXON Pharma N.V.: Noxxon Reports 2021 Financial Results :

Regulatory News: NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX) (Paris:ALNOX), a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME)

Related Keywords

Germany , Illinois , United States , Paris , France General , France , Chicago , American , Eileenm Oreilly , Guillaume Van Renterghem , Thomastw Seufferlein , Arthur Rouill , Bryan Jennings , Aram Mangasarian , Frank Giordano , Susan Coles , Pharmanv Euronext , Merck Keytruda , Jose Saro , Elena Gabriela Chiorean , Joyce Fearon , American Society Of Clinical Oncology , Linkedin , Twitter , Merck Co , Company Stock Option Plan , Merck Sharp Dohme Corp , Society For Neuro , Life Sciences , Regulatory News , Euronext Growth Paris , Annual Report , Advisory Board , Supervisory Board , Senior Vice President Corporate Strategy , General Counsel , Vivet Therapeutics , Annual Meeting , Clinical Oncology , Cancer Phase , Atlas Special Opportunities , Stock Option , Brain Cancer , Pancreatic Cancer , Solid Tumors , Merck Sharp Dohme , Executive Officer , Media Relations , Noxxon , Dharma , Reports , 021 , Financial , Results ,